GRPR and neoplasm: The GRPR positive tumor-targeting potential of [68Ga]Ga-NODAGA-AMBA and [44Sc]Sc-NODAGA-AMBA was investigated by preclinical PET imaging 60 and 120 min after intravenous radiotracer injection.